Story thread · 2 reports / 2 sources
Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals
cnbc.com · 8h · first report
How the coverage leans
Across 2 sources · syndicated copies counted once
Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.
The coverage
- Chinese biopharma stocks rally as U.S. signals openness to drug licensing
seekingalpha.com · 3h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.